Is Scribe Therapeutics Inc. (SCTX) a Buy, Sell, or Hold?
NASDAQ : SCTX
Scribe Therapeutics Inc.
$24.93 USD
-$1.07 (-4.12%)
- Volume
- 149.88K
- Average Volume
- 270.33K
- Market Capitalization
- $403.42M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $26.50
- Year Low
- $17.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
NASDAQ
Benjamin L. Oakes
Biotechnology
Healthcare
SCTX
89
US
USD
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Benjamin L. Oakes | Co-Founder, President, CEO & Chairman |
| Jennifer A. Doudna | Co-Founder & Scientific Advisor |
| David F. Savage | Co-Founder & Scientific Advisor |
| Svetlana Lucas | Chief Business Officer |
| Brett T. Staahl | Co-Founder & VP of External Innovation |
| David L. Parrot | CFO & Treasurer |
| George Manning | VP & Controller |
| Richard Hector | Head of Intellectual Property |
| Sunny Mok | Senior Vice President of Operations |
| Chitra Sharma | Senior Vice President of Development |
| Stephen V. Thau | Secretary |
Poll Results
No votes yet today — be the first to share your view!
About Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock
Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention. ...
2026-07-27 16:05:00
ALAMEDA, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the closing of its upsized initial public offering of 9,867,000 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase 1,287,000 additional shares, at the initial public offering price of $15.00 per share.
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
2026-07-23 21:08:00
ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, today announced the pricing of its upsized initial public offering of 8,580,000 shares of its common stock at the high end of the range at a public offering price of $15.00 per share.
Frequently Asked Questions
-
What is the current Scribe Therapeutics Inc. (SCTX) stock price?
-
Scribe Therapeutics Inc.(NASDAQ:SCTX) stock price is $24.93 in the last trading session. During the trading session, SCTX stock reached the peak price of $26.5 while $17.31 was the lowest point it dropped to. The percentage change in SCTX stock occurred in the recent session was --4.12% while the dollar amount for the price change in SCTX stock was -$1.07.
-
SCTX's industry and sector of operation?
-
The NASDAQ listed SCTX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of SCTX?
-
Benjamin L. Oakes | Co-Founder, President, CEO & Chairman
Jennifer A. Doudna | Co-Founder & Scientific Advisor
David F. Savage | Co-Founder & Scientific Advisor
Svetlana Lucas | Chief Business Officer
Brett T. Staahl | Co-Founder & VP of External Innovation -
How many employees does SCTX have?
-
Number of SCTX employees currently stands at 89. SCTX operates from 1150 MARINA VILLAGE PARKWAY, Alameda, CA 94501, US.
-
Link for SCTX official website?
-
Official Website of SCTX is: http://www.scribetx.com
-
How do I contact SCTX?
-
SCTX could be contacted at phone #None and can also be accessed through its website. SCTX operates from 1150 MARINA VILLAGE PARKWAY, Alameda, CA 94501, US.
-
How many shares of SCTX are traded daily?
-
The average number of SCTX shares traded daily for last 3 months was 270.33K.
-
What is the market cap of SCTX currently?
-
The market value of SCTX currently stands at $403.42M with its latest stock price at $24.93